Centrus Energy's Revenues Slip 2% in 1H25: Recovery Ahead?

Centrus Energy reported a 2% year-over-year revenue decline to $227.6 million in the first half of 2025, primarily driven by an 8% drop in its Low-Enriched Uranium (LEU) segment due to the absence of uranium sales, despite strong growth in its Technical segment. Despite this, the company projects a 2.75% revenue increase for the full year 2025 to $454 million, anticipating renewed uranium sales in the second half, supported by a bullish uranium market with prices surging to $83.50/lb amid global nuclear capacity expansion plans and supply constraints. However, Centrus trades at a significant forward price-to-sales premium of 14.59X compared to the industry average, and analysts project declining EPS for 2025 and 2026.

Analysis

Centrus Energy (LEU) reported a 2% year-over-year revenue decline to $227.6 million in the first half of 2025. This was primarily driven by an 8% decrease in its Low-Enriched Uranium (LEU) segment revenues to $177 million, attributed to the absence of uranium sales, which generated $29.9 million in 1H24. Despite an 8% increase in Separative Work Units (SWU) revenues within the LEU segment, a 12% decrease in SWU volume offset a 24% price increase, while the Technical segment saw robust 66% revenue growth.

Despite the 1H25 revenue slip, Centrus projects full-year 2025 revenues to increase 2.75% to $454 million, anticipating renewed uranium sales in the second half. This optimistic outlook is supported by a bullish uranium market, with prices surging to $83.50 per pound, fueled by global nuclear capacity expansion plans (e.g., US quadrupling capacity by 2050, India to 100 GW by 2047) and supply constraints from major producers like Cameco and Kazatomprom.

However, Centrus shares have significantly outperformed, soaring 494.8% year-to-date, leading to a forward 12-month price/sales multiple of 14.59X, a substantial premium to the industry's 3.67X. This high valuation contrasts with Zacks Consensus Estimates, which project a 3.4% year-over-year decline in 2025 EPS to $4.32 and a further 24.7% decline in 2026 EPS to $3.25.

Key Decisions for Investors

• Investors should closely monitor Centrus Energy's 2H25 uranium sales performance and the actualization of projected revenue growth, as 1H25 results were impacted by the absence of these sales.
• Given the significant valuation premium (14.59X P/S vs. industry 3.67X) and projected EPS declines for 2025 and 2026, investors should carefully assess the stock's current price against future earnings potential and market expectations.
• Consider the broader uranium market trends, including global nuclear expansion and supply dynamics, as these factors are critical for Centrus's long-term revenue and profitability, particularly if 2H25 uranium sales materialize as expected.